Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
- 1 March 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (3) , 359-368
- https://doi.org/10.1016/s0168-8278(98)80307-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled studyBone Marrow Transplantation, 1997
- A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infectionJournal of Viral Hepatitis, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver tnrasplantation ? A pilot studyHepatology, 1995
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyPublished by Elsevier ,1991
- Hepatitis B infection in patients with lymphomasHematological Oncology, 1990
- Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantationDigestive Diseases and Sciences, 1988
- Reactivation of chronic hepatitis B virus infectionGastroenterology, 1987
- Reactivation of Chronic Hepatitis B Virus Infection by Cancer ChemotherapyAnnals of Internal Medicine, 1982
- FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPYThe Lancet, 1975